Nuestra lista de correo. Espera aprobación.
Correo electrónico:
Consultar este grupo

jueves, 30 de junio de 2016

Guide to Implementing a Safety Culture in our Universities

This guide is a roadmap for a university-wide effort to strengthen a culture of research safety. The guide has action steps, resources, and recommendations to help navigate the challenge of changing the culture of the institution. The guide is intended for university presidents and chancellors who have made a renewed commitment to improve their institutional culture of safety, and it is intended for the campus leadership team that the president appoints to helm this effort. The task force encourages each institution to use the guide in ways that fits their unique institutional contexts. The task force has identified 20 recommendations for implementing and sustaining a culture of academic and research safety, primarily drawn from four foundational reports: Safe Science: Promoting a Culture of Safety in Academic Chemical Research (National Research Council, 2014); Creating Safety Cultures in Academic Institutions (ACS, 2012); Creating a Safety Culture (OSHA, 1989); and Texas Tech Laboratory Explosion Case Study (CSB, 2010). This guide includes an analysis showing the alignment of the 20 recommendations with these key national reports.
The recommendations are organized in four overarching categories: institution-wide dynamics and resources; data, hazard identification, and analysis; training and learning; and continuous improvement. For each recommendation, the task force has provided reading lists, tools, strategies, illustrative examples, and/or best practices drawn from a community of stakeholders for implementing these recommendations.  These resources were selected to help an appointed campus team navigate the process of strengthening their culture of safety.

APLU Council on Research Task Force on Laboratory Safety (2016). A Guide to Implementing
a Safety Culture in Our Universities. CoR Paper 1. Washington, DC: Association of Public and
Land-grant Universities.
Sigue este Blog en Facebook y Twitter

lunes, 27 de junio de 2016

The Respiratory Protection Effectiveness Clinical Trial (ResPECT)

BACKGROUND: Although N95 filtering facepiece respirators and medical masks are commonly used for protection against respiratory infections in healthcare settings, more clinical evidence is needed to understand the optimal settings and exposure circumstances for healthcare personnel to use these devices. A lack of clinically germane research has led to equivocal, and occasionally conflicting, healthcare respiratory protection recommendations from public health organizations, professional societies, and experts.
METHODS: The Respiratory Protection Effectiveness Clinical Trial (ResPECT) is a prospective comparison of respiratory protective equipment to be conducted at multiple U.S. study sites. Healthcare personnel who work in outpatient settings will be cluster-randomized to wear N95 respirators or medical masks for protection against infections during respiratory virus season. Outcome measures will include laboratory-confirmed viral respiratory infections, acute respiratory illness, and influenza-like illness. Participant exposures to patients, coworkers, and others with symptoms and signs of respiratory infection, both within and beyond the workplace, will be recorded in daily diaries. Adherence to study protocols will be monitored by the study team.
DISCUSSION: ResPECT is designed to better understand the extent to which N95s and MMs reduce clinical illness among healthcare personnel. A fully successful study would produce clinically relevant results that help clinician-leaders make reasoned decisions about protection of healthcare personnel against occupationally acquired respiratory infections and prevention of spread within healthcare systems.
TRIAL REGISTRATION:  The trial is registered at, number NCT01249625 (11/29/2010).
KEYWORDS: Healthcare personnel; Influenza; Masks; Respirators; Respiratory infections
Radonovich LJ Jr, et al. The Respiratory Protection Effectiveness Clinical Trial (ResPECT): a cluster-randomized comparison of respirator and medical mask effectiveness against respiratory infections in healthcare personnel. BMC Infect  Dis. 2016 Jun 2;16(1):243.
Sigue este Blog en Facebook y Twitter

lunes, 20 de junio de 2016


La gestión de riesgo biológico es fundamental para la Asociación Mexicana de Bioseguridad A.C., por lo cual se acordó en Junio de 2014, elaborar estos lineamientos, basados en el contenido del documento CWA15793:2011: Laboratory Biorisk Management. Aunque se mantuvo la estructura básica del CWA15793, estos lineamientos se distinguen en múltiples aspectos. Además se ha verificado que se respete la propiedad intelectual del Comité Europeo de Normalización sobre el CWA15793:2011 en su versión en lengua española UNE-CWA 15793:2013).

La AMEXBIO pone a CONSULTA PÚBLICA su BORRADOR DE LOS LINEAMIENTOS PARA LA GESTIÓN DE RIESGO BIOLÓGICO (PDF). Se recibirán comentarios del 25 de mayo al 9 de julio de 2016 en el formato designado únicamente.  ¡Gracias por el apoyo!

Sigue este Blog en Facebook y Twitter